Stock RVV REVIVE THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Charts Revive Therapeutics Ltd.

Equities

RVV

CA7615161030

Delayed Canadian Securities Exchange
Other stock markets
 09:56:15 2024-05-03 am EDT 		5-day change 1st Jan Change
0.025 CAD 0.00% Intraday chart for Revive Therapeutics Ltd. -16.67% -16.67%
Apr. 23 FDA Grants Revive Therapeutics Type C Meeting Request For Bucillamine Study to Treat Long COVID MT
Apr. 23 Revive Therapeutics Brief: Announcing Type C Meeting Request Granted by FDA for Clinical Study of Bucillamine to Treat Long COVID MT

Chart: Technical Analysis

Technical analysis trends

Short TermMid-TermLong Term
Trend

Bearish

Bearish

Bearish

Resistance 0.0300 0.0320 0.0400
Spread/Res.-16.67%-21.88%-37.50%
Spread/Supp.+19.05%+19.05%+47.06%
Support 0.0210 0.0210 0.0170
  1. Stock Market
  2. Equities
  3. RVV Stock
  4. Charts Revive Therapeutics Ltd.